UniFirst heads into the back half of July with one striking tension: short interest has surged dramatically while the stock continues to grind higher.
The short positioning story is the headline this week. Shorts have nearly doubled in a month — SI climbed 60% in 30 days to reach 5.7% of the free float, with almost all of that move happening in a single step around July 9-10, when shares short jumped from roughly 524,000 to 836,000 overnight. That kind of step-change is unusual. It points to a deliberate positioning decision by one or more significant players rather than gradual accumulation. Yet the borrow market tells a different story entirely: cost to borrow is running near 0.41%, well below its recent range, and availability is extraordinarily loose at over 6,000% — meaning there are roughly 60 shares available to borrow for every one currently lent out. Short sellers are adding aggressively, but they're doing it cheaply and with no friction in the lending pool. There's no squeeze pressure here.
Options positioning reinforces the cautious tone without amplifying it. The put/call ratio is 1.93, running just above its 20-day average of 1.86 — a z-score barely above zero. That's a structurally defensive book, but not one that's been rattled further by the recent short buildup. What is notable in the options history is the sharp jump in the PCR in late June, from around 1.30 to over 2.10, which has since partially retreated. That earlier spike predated the short interest move, suggesting hedging demand ran ahead of the short sellers.
The Street is cautiously positioned but not outright bearish. The analyst consensus picture hasn't shifted in recent months — UBS holds a Neutral with a $260 target and Barclays an Equal-Weight at $280, both modestly below the current price of $275. That leaves the mean target at roughly $273, fractionally below the close. The valuation setup is correspondingly full: the stock trades at nearly 35x earnings and 13.6x EV/EBITDA, with price-to-book at 1.73. The 30-day PE compression of about 0.9 turns is modest, suggesting the multiple hasn't yet been tested by the re-emergence of short interest. Factor scores reflect the mixed setup — momentum ranks in the upper half and days-to-cover in the 64th percentile, but EPS momentum over 30 days sits at just 37, and the short score rank is a subdued 32.
One institutional move worth flagging: Vanguard Portfolio Management added a full 820,469 shares in Q1, a position built from zero according to the latest reported data. That's a meaningful new stake worth roughly $225 million at current prices, arriving at roughly the same time Barclays upgraded the stock from Underweight to Equal-Weight in early March. BlackRock, the largest holder at 11.8% of shares, added modestly in Q2. The two largest passive players are both net buyers while the short interest surges — a structural divergence that defines the stock's current tension.
The next catalyst is Q1 earnings on October 21. The recent earnings history is modestly positive — the July 1 result produced a 3.4% one-day gain, and the April print added 1.8%. What to watch between now and then is whether the short interest consolidates near 5.7% or continues to build, and whether the step-change on July 9-10 turns out to be the opening of a new trade or a position that begins to cover as the stock holds above $270.
See the live data behind this article on ORTEX.
Open UNF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
